Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 118 B, Issue 1, 2003, Pages 103-109

  Qian, Qiujin ^a   Wang, Yufeng ^a   Zhou, Rulun ^a   Li, Jun ^a   Wang, Bing ^a   Glatt, Stephen ^b,d   Faraone, Stephen V ^c,d  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Harvard Inst Psychiat E/G   (United States)

Author keywords

Association; Attention deficit hyperactivity disorder; Catechol O methyltransferase; Gender differences; Genetics

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE; DNA;

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FAMILY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALITY; PHENOTYPE; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE; TECHNIQUE; ADULT; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; FAMILY HEALTH; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HAPLOTYPE; MISSENSE MUTATION; NUCLEAR FAMILY;

ADOLESCENT; ADULT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; CHILD; DNA; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; METHIONINE; MUTATION, MISSENSE; NUCLEAR FAMILY; PHENOTYPE; POLYMORPHISM, GENETIC; SEX FACTORS; VALINE;

EID: 0038755196     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.10064     Document Type: Article

References (38)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th edition. (DSM-IV). Washington, DC: American Psychiatric Association.
2. Andersen SL, Teicher MH. 2000. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 24:137-141.
3. Barkley RA. 1998. Attention-deficit hyperactivity disorder: A clinical workbook. 2nd edition. New York: Guilford. pp 39-55.
4. Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W, Kennedy JL. 1999. Linkage study of catechol-O-methyltransferase and attention deficit hyperactivity disorder. Am J Med Genet 88:710-713.
5. Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, Belmaker RH, Ebstein RP. 2000. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: Dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR), and catechol-O-methyltransferase (COMT). Mol Psychiatry 5:96-100.
6. Biederman J, Munir K, Knee D, Habelow W, Armentano M, Autor S, Hoge SK, Waternaux C. 1986. A family study of patients with attention deficit disorder and normal controls. J Psychiatr Res 20:263-274.
7. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, et al. 1992. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referral samples. Arch Gen Psychiatry 49:728-738.
8. Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. 1997. Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 41:985-987.
9. Cohen P, Cohen J, Kasen S, Velez CN, Hartmark C, Johnson J, Rojas M, Brook J, Streuning EL. 1993. An epidemiological study of disorders in late childhood and adolescence-I. Age- and gender-specific prevalence. J Child Psychol Psychiatry 34(6):851-867.
10. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val1O8/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
11. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, Ebstein RP. 1999. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 88:497-502.
12. Ernst M, Liebenauer LL, King C, Fitzgerald GA, Cohen RM, Zametkin AJ. 1994. Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 33:858-868.
13. Ewens WJ. 1996. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 59:983-989.
14. Faraone SV, Biederman J. 1998. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44:951-958.
15. Faraone SV, Doyle A. 2001. The nature and heritability of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clinics North America 10:299-316.
16. Faraone SV, Biederman J, Milberger S. 1994. An exploratory study of ADHD among second-degree relatives of ADHD children. Biol Psychiatry 35:398-402.
17. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, PfaffD, Karayiorgou M. 1998. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:9991-9996.
18. Grossman MH, Emanuel BS, Budarf ML. 1992. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2 Genomics 12(4):822-825.
19. Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M. 2000. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet 96:282-284.
20. Horowitz R, Shufman A, Aharoni S, Aharoni S, Kremer I, Cohen H, Ebstein RP. 2000. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet 96:599-603.
21. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA. 1997. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572-4575.
22. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178-1189.
23. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, Nemanov L, Ebstein RP. 1999. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol-O-methyltransferase (COMT) activity. Am J Med Genet 88:628-633.
24. Lachman HM, Morrow B, Shprintzen R, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF. 1996. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67(5):468-472.
25. Li T, Sham PC, Vallada H, Xie T, Tang X, Murray RM, Liu X, Collier DA. 1996. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatric Genet 6(3):131-133.
26. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. 1995. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: A revised mechanism and description of thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
27. Manor I, Kotler M, Sever Y, Eisenberg J, Cohen H, Ebstein RP, Tyano S. 2000. Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet 96:858-860.
28. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. 1997. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings. Am J Addiction 6:205-217.
29. Morrow B, Goldberg R, Carxon C, Das Gupta R, Sirotkin H, Collins J, Munham I, O'Donnell H, Scambler P, Shprintzen R, et al. 1995. Molecular definition of 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet 56:1391-1403.
30. Nolan KA, Volavka J, Czobor P, Cseh A, Lachman H, Saito T, Tiihonen J, Putkonen A, Hallikainen T, Kotilainen I, Rasanen P, Isohanni M, Jarvelin MR, Karvonen MK. 2000. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatric Genet 10(3):117-124.
31. Ovtscharoff W, Euaterschulte B, Zienecker R, Reisert I, Pilgrim C. 1992. Sex differences in densities of dopaminergic fibers and GABAergic neurons in the prenatal rat striatum. J Comp Neurol 323: 299-304.
32. Palmatier MA, Min-Kang A, Kidd KK. 1999. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46:557-567.
33. Scalon PD, Raymond FA, Weinshilboum X. 1979. Catechol-O-methyltransferase thermolabile enzyme in erythrocytes of subjects for allele for low activity. Science 203:63-65.
34. Shprintzen RJ, Goldberg RB, Golding-Kushner KJ, Marion RW. 1992. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42:141-142.
35. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
36. Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson PJ. 2000. No association between low- and high-activity catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am J Med Genet 96:285-288.
37. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM. 1997. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74:439-442.
38. Weinshilboum R, Dunnette J. 1981. Thermal stability and biochemical genetics of erythrocyte catechol-O-methyltransferase and plasma dopamine-beta-hydroxylase. Clin Genet 19:426-437.